Healthcare Services

A Significant Growth Driver for the Real-Time PCR, Digital PCR And End-Point PCR Market Is the Elevated Prevalence Of Infectious Diseases Fueling Growth In The Real-Time PCR, Digital PCR, And End-Point PCR Market

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Real-Time PCR, Digital PCR And End-Point PCR Market By The End Of 2030?

The real-time pcr, digital pcr and end-point pcr market size has experienced significant expansion in recent years. Its value is projected to rise from $41.55 billion in 2025 to $45.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to the broadening of molecular diagnostics applications, the increasing prevalence of infectious diseases, the expanded use of pcr in clinical research, the development of genetic testing laboratories, and the accessibility of advanced pcr instruments.

The real-time pcr, digital pcr and end-point pcr market is projected to observe swift expansion over the next few years. It is forecast to attain a size of $67.76 billion by 2030, progressing at a compound annual growth rate (CAGR) of 10.5%. The projected growth is attributable to the increasing uptake of personalized medicine diagnostics, rising investments in genomics research, the expansion of point-of-care molecular testing, a growing demand for ultra-sensitive detection methods, and increased automation in molecular laboratories. Significant trends identified for the forecast period include the increasing adoption of digital pcr for precision quantification, a rising demand for high-throughput pcr systems, the growing utilization of multiplex pcr assays, the expansion of automated pcr workflows, and an enhanced focus on data accuracy and sensitivity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Which Market Drivers Are Supporting The Expansion Of The Real-Time PCR, Digital PCR And End-Point PCR Market?

The anticipated rise in the incidence of infectious diseases is projected to propel the expansion of the real-time PCR, digital PCR, and end-point PCR markets moving forward. Infectious diseases are defined as illnesses resulting from the invasion and proliferation of pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR methods are applied in infectious disease management to quantify specific pathogens or their genetic material, monitor the progression of the disease, and provide rapid diagnoses for infections like HIV, hepatitis, respiratory viruses, and tuberculosis. As an illustration, in March 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking a rise of 1,295 cases. Hence, the increasing occurrence of infectious diseases will stimulate the growth of the cephalosporin market.

Which Segment Classifications Shape The Real-Time PCR, Digital PCR And End-Point PCR Market?

The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software And Services

2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital

3) By Applications: Clinical, Research, Forensic, Other Applications

4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Subsegments:

1) By Instruments: Real-Time PCR Systems, Digital PCR Systems, End-Point PCR Systems

2) By Consumables And Reagents: PCR Plates And Tubes, Primers And Probes, PCR Master Mix, DNA Polymerases And Nucleotides

3) By Software And Services: Analysis Software, Data Management Software, Calibration And Maintenance Services, Training And Support Services

What Trends Are Affecting The Expansion Of The Real-Time PCR, Digital PCR And End-Point PCR Market?

Leading companies in the real-time PCR, digital PCR, and end-point PCR markets are concentrating on developing next-generation platforms to boost assay sensitivity, refine precision, and enhance overall clinical performance. These advancements aim to enable highly accurate detection of low-abundance nucleic acids, rare mutations, and copy number variations (CNVs), supporting both research and clinical diagnostic applications. Digital PCR, in particular, offers absolute quantification capabilities, making it valuable for applications requiring high sensitivity and reproducibility. For instance, in September 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the QIAcuityDx Digital PCR System for clinical oncology diagnostics, along with over 100 newly validated assays through its GeneGlobe platform. The system integrates sample partitioning, thermocycling, and imaging into a single automated workflow, facilitating streamlined operations for clinical and research laboratories. Designed to support applications such as non-invasive liquid biopsy testing, the QIAcuityDx platform underscores QIAGEN’s commitment to advancing diagnostic accuracy and improving clinical outcomes.

Which Companies Are Expanding Their Footprint In The Real-Time PCR, Digital PCR And End-Point PCR Market?

Major companies operating in the real-time pcr, digital pcr and end-point pcr market are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Read the full real-time pcr, digital pcr and end-point pcr market report here:

https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

How Is The Real-Time PCR, Digital PCR And End-Point PCR Market Distributed Across Key Geographic Regions?

North America was the largest region in the real-time PCR, digital PCR, and end-point PCR market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time pcr, digital pcr and end-point pcr market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real-Time PCR, Digital PCR And End-Point PCR Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13296&type=smp

Browse Through More Reports Similar to the Global Real-Time PCR, Digital PCR And End-Point PCR Market 2026, By The Business Research Company

Gait Analyzer Global Market Report

https://www.thebusinessresearchcompany.com/report/gait-analyzer-global-market-report

Extended Reality Display Global Market Report

https://www.thebusinessresearchcompany.com/report/extended-reality-display-global-market-report

Full Body Motion Capture Software Global Market Report

https://www.thebusinessresearchcompany.com/report/full-body-motion-capture-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795